Guo Pan, Tao Fang, Du Lili, Yang Hongmei, Wang Wenguang, Ma Chunpeng, Bi Xile, Ren Lin, Yin Hongtao, Ma Lixiang
Department of Cardiology, Qinhuangdao First Hospital, Qinhuangdao, Hebei, China.
Medical Department, Qinhuangdao First Hospital, Qinhuangdao, Hebei, China.
Front Med (Lausanne). 2025 Jul 22;12:1555478. doi: 10.3389/fmed.2025.1555478. eCollection 2025.
Acute kidney injury (AKI) following acute myocardial infarction (AMI) notably affects patient outcomes. The impact of KDIGO AKI staging on post-discharge short- and long-term outcomes, particularly early-stage AKI, is not well understood. This study evaluates the prognostic implications of various KDIGO stages in AMI patients.
Utilizing the Medical Information Mart for Intensive Care IV (version 3.0) database, this retrospective cohort study included adult patients primarily diagnosed with AMI. Statistical analyses, including doubly robust estimation, propensity score matching, logistic regression, and Cox regression, were performed. The study compared Non-AKI (KDIGO stage 0) with Mild-AKI (maximum KDIGO stage 1 during hospitalization), and Normal-or-mild AKI (KDIGO stages 0-1) with Moderate-to-severe AKI (KDIGO stages 2-3).
Among 5,715 patients analyzed, 4,306 (75.36%) developed AKI. Doubly robust analysis revealed no significant differences in outcomes between Non-AKI and Mild-AKI groups (28-day mortality: OR 0.97, 95% CI 0.68-1.38; 180-day mortality: HR 0.94, 95% CI 0.76-1.18; 1-year mortality: HR 0.98, 95% CI 0.81-1.20). However, Moderate-to-severe AKI was significantly associated with worse outcomes compared to Normal-or-mild AKI (28-day mortality: OR 1.67, 95% CI 1.36-2.05; 180-day mortality: HR 1.06, 95% CI 1.02-1.10; 1-year mortality: HR 1.22, 95% CI 1.07-1.38; all < 0.001). Subgroup analyses revealed that patients under 65 years with Mild-AKI showed higher risks of 180-day and 1-year mortality compared to Non-AKI, while Moderate-to-severe AKI consistently demonstrated worse outcomes across all subgroups (age, SOFA score, heart failure status, and renal disease status). These findings were robust across multiple sensitivity analyses.
Patients with Mild-AKI can be considered as having "subclinical AKI," with prognoses similar to Non-AKI patients. In contrast, Moderate-to-severe AKI significantly worsens prognosis compared to Normal-or-mild AKI.
急性心肌梗死(AMI)后发生的急性肾损伤(AKI)显著影响患者预后。KDIGO AKI分期对出院后短期和长期预后的影响,尤其是早期AKI,目前尚不清楚。本研究评估了AMI患者不同KDIGO分期的预后意义。
利用重症监护医学信息数据库IV(版本3.0),这项回顾性队列研究纳入了主要诊断为AMI的成年患者。进行了包括双重稳健估计、倾向评分匹配、逻辑回归和Cox回归在内的统计分析。该研究将非AKI(KDIGO 0期)与轻度AKI(住院期间最高KDIGO 1期),以及正常或轻度AKI(KDIGO 0-1期)与中重度AKI(KDIGO 2-3期)进行了比较。
在分析的5715例患者中,4306例(75.36%)发生了AKI。双重稳健分析显示,非AKI组和轻度AKI组在预后方面无显著差异(28天死亡率:OR 0.97,95%CI 0.68-1.38;180天死亡率:HR 0.94,95%CI 0.76-1.18;1年死亡率:HR 0.98,95%CI 0.81-1.20)。然而,与正常或轻度AKI相比,中重度AKI与更差的预后显著相关(28天死亡率:OR 1.67,95%CI 1.36-2.05;180天死亡率:HR 1.06,95%CI 1.02-1.10;1年死亡率:HR 1.22,95%CI 1.07-1.38;均P<0.001)。亚组分析显示,65岁以下的轻度AKI患者与非AKI患者相比,180天和1年死亡率风险更高,而中重度AKI在所有亚组(年龄、序贯器官衰竭评估(SOFA)评分、心力衰竭状态和肾脏疾病状态)中始终表现出更差的预后。这些发现在多项敏感性分析中均很稳健。
轻度AKI患者可被视为患有“亚临床AKI”,其预后与非AKI患者相似。相比之下,与正常或轻度AKI相比,中重度AKI显著恶化预后。